Jan Erik Henriksen

Decreased insulin activation of glycogen synthase in skeletal muscles in young nonobese Caucasian first-degree relatives of patients with non-insulin-dependent diabetes mellitus.

Allan Vaag, Jan Erik Henriksen, Henning Beck‐Nielsen · Journal of Clinical Investigation · 1992 · 304 citations · Full text

Medicine, Endocrinology, Physiology +16

Efficacy and safety of dapagliflozin in patients with inadequately controlled type 1 diabetes (DEPICT-1): 24 week results from a multicentre, double-blind, phase 3, randomised controlled trial

Paresh Dandona, Chantal Mathieu, Moshe Phillip et al. · The Lancet Diabetes & Endocrinology · 2017 · 292 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +10

Efficacy and Safety of Dapagliflozin in Patients With Inadequately Controlled Type 1 Diabetes: The DEPICT-1 52-Week Study

Paresh Dandona, Chantal Mathieu, Moshe Phillip et al. · Diabetes Care · 2018 · 238 citations

Medicine, Pharmacology, Pharmacotherapy +17

Prediction of First Cardiovascular Disease Event in Type 1 Diabetes Mellitus

Dorte Vistisen, Gregers S. Andersen, Christian Stevns Hansen et al. · Circulation · 2016 · 231 citations

Public Health, Biostatistics, Epidemiology +16

Insulin secretion, insulin action, and hepatic glucose production in identical twins discordant for non-insulin-dependent diabetes mellitus.

Allan Vaag, Jan Erik Henriksen, Sten Madsbad et al. · Journal of Clinical Investigation · 1995 · 211 citations · Full text

Medicine, Endocrinology, Internal Medicine +14